Form D · Biotechnology

Merganser Biotech, Inc.

King Of Prussia, PA · CIK 0001635172

Offering snapshot reported Apr 29, 2016 · SEC filing

Reported sold
$13.1M
Offering amount: $17.1M
Investors reported
24
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 13, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$6.55M$13.1MFeb 27, 2015: $8,000,017.00Feb 27, 2015Apr 29, 2016: $13,097,190.00Apr 29, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$8,000,017 → $13,097,190

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 29, 2016Amendment$13,097,190$5,097,173vs Feb 27, 201524SEC filing
Feb 27, 2015Initial$8,000,017No comparison24SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-234935

Source: Form D, filed Apr 29, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeffrey Bird Director
Colin Goddard Director
Markus Goebel Director
Brian Mac Donald Director, Executive
Remy Sukhija Executive
James Topper Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1004 West 9th Avenue, Suite 115
King Of Prussia, PA, 19406